(2022). EPH154 assessment of performance characteristics of covid-19 CIE-10-CM diagnosis code U07.1 using Sars-COV-2 nucleic acid amplification test results in the us fda best network.
Chicago Style (17th ed.) CitationEPH154 Assessment of Performance Characteristics of Covid-19 CIE-10-CM Diagnosis Code U07.1 Using Sars-COV-2 Nucleic Acid Amplification Test Results in the Us Fda Best Network. 2022.
MLA (8th ed.) CitationEPH154 Assessment of Performance Characteristics of Covid-19 CIE-10-CM Diagnosis Code U07.1 Using Sars-COV-2 Nucleic Acid Amplification Test Results in the Us Fda Best Network. 2022.
Warning: These citations may not always be 100% accurate.